Novo-Rythro Estolate

ODB Formulary Therapeutic Classification

• 08:12:12 Erythromycins

Therapeutic Note

Antibiotics, Erythromycins (8:12:12): Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.

ATC Code

J01FA01

Interchangeable Products

 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph